Premier Other Long-Term Assets 2012-2024 | PINC
Premier other long-term assets from 2012 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Premier Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $103 |
| 2023 | $110 |
| 2022 | $114 |
| 2021 | $77 |
| 2020 | $94 |
| 2019 | $32 |
| 2018 | $4 |
| 2017 | $10 |
| 2016 | $12 |
| 2015 | $17 |
| 2014 | $16 |
| 2013 | $37 |
| 2012 | $25 |
| 2011 | $0 |
| Premier Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $96 |
| 2024-09-30 | $103 |
| 2024-06-30 | $99 |
| 2024-03-31 | $99 |
| 2023-12-31 | $96 |
| 2023-09-30 | $109 |
| 2023-06-30 | $110 |
| 2023-03-31 | $110 |
| 2022-12-31 | $117 |
| 2022-09-30 | $109 |
| 2022-06-30 | $114 |
| 2022-03-31 | $113 |
| 2021-12-31 | $67 |
| 2021-09-30 | $72 |
| 2021-06-30 | $77 |
| 2021-03-31 | $80 |
| 2020-12-31 | $84 |
| 2020-09-30 | $90 |
| 2020-06-30 | $94 |
| 2020-03-31 | $98 |
| 2019-12-31 | $35 |
| 2019-09-30 | $38 |
| 2019-06-30 | $32 |
| 2019-03-31 | $33 |
| 2018-12-31 | $30 |
| 2018-09-30 | $23 |
| 2018-06-30 | $4 |
| 2018-03-31 | $4 |
| 2017-12-31 | $5 |
| 2017-09-30 | $9 |
| 2017-06-30 | $10 |
| 2017-03-31 | $13 |
| 2016-12-31 | $14 |
| 2016-09-30 | $19 |
| 2016-06-30 | $12 |
| 2016-03-31 | $29 |
| 2015-12-31 | $25 |
| 2015-09-30 | $32 |
| 2015-06-30 | $17 |
| 2015-03-31 | $52 |
| 2014-12-31 | $50 |
| 2014-09-30 | $49 |
| 2014-06-30 | $16 |
| 2014-03-31 | $44 |
| 2013-12-31 | $44 |
| 2013-09-30 | $33 |
| 2013-06-30 | $37 |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | $25 |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.087B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.708B | 26.39 |
| Elevance Health (ELV) | United States | $84.816B | 10.94 |
| CVS Health (CVS) | United States | $76.534B | 9.51 |
| Cencora (COR) | United States | $54.103B | 18.81 |
| DiDi Global (DIDIY) | China | $21.367B | 32.43 |
| Natera (NTRA) | United States | $20.793B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.720B | 13.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.739B | 0.00 |
| Revvity (RVTY) | United States | $11.399B | 19.62 |
| CochLear (CHEOY) | Australia | $11.361B | 0.00 |
| ICON (ICLR) | Ireland | $11.346B | 10.55 |
| Doximity (DOCS) | United States | $11.282B | 58.67 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $9.063B | 13.17 |
| Medpace Holdings (MEDP) | United States | $8.914B | 23.68 |
| HealthEquity (HQY) | United States | $8.389B | 41.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.074B | 13.86 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| BrightSpring Health Services (BTSG) | United States | $4.049B | 37.48 |
| Sotera Health (SHC) | United States | $3.758B | 21.35 |
| Surgery Partners (SGRY) | United States | $2.939B | 38.22 |
| Alignment Healthcare (ALHC) | United States | $2.780B | 0.00 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.194B | 2.33 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| GeneDx Holdings (WGS) | United States | $1.739B | 66.96 |
| PACS (PACS) | United States | $1.669B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.650B | 30.71 |
| Teladoc Health (TDOC) | United States | $1.337B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.239B | 9.42 |
| Agilon Health (AGL) | United States | $1.118B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.011B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.898B | 14.03 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| Embecta (EMBC) | United States | $0.731B | 4.92 |
| Nutex Health (NUTX) | United States | $0.696B | 10.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Enhabit (EHAB) | United States | $0.530B | 43.62 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 13.51 |
| Sonida Senior Living (SNDA) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.387B | 0.00 |
| SBC Medicals (SBC) | United States | $0.363B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.362B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Sera Prognostics (SERA) | United States | $0.089B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| KindlyMD (KDLY) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |